Data from the analytical performance of the Abaxis Piccolo Xpress point of care analyzer in whole blood, serum, and plasma
Kazunori Murata,
Laurel Glaser,
Mary Nardiello,
Lakshmi V. Ramanathan,
Dean C. Carlow
Affiliations
Kazunori Murata
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
Laurel Glaser
Department of Pathology and Laboratory Medicine, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
Mary Nardiello
Department of Pathology and Laboratory Medicine, Children's Hospital of Philadelphia, Philadelphia, USA
Lakshmi V. Ramanathan
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
Dean C. Carlow
Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, USA; Corresponding to: Dean Carlow, M.D. Ph.D. Department of Laboratory Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue New York, NY 10065.
The objective of this study was to examine the analytical performance of 14 comprehensive metabolic panel analytes on the Abaxis Piccolo Xpress® Point of Care analyzer in serum, plasma, and whole blood. A method comparison was performed on all three specimen types intended for use on the Piccolo Xpress®: serum, heparinized plasma, and whole blood. This data is also presented in Murata et al. (2015) [1]. This article includes the actual Bland-Altman bias plots of the difference in results obtained for analytes in the comprehensive metabolic panel from the Abaxis Piccolo Xpress and the comparison instrument, the Ortho Vitros. Keywords: Clinical chemistry, Point-of care testing
